55 results
Abrilada (adalimumab-afzb)
(adalimumab-afzb)Pfizer Laboratories Div Pfizer Inc
Usage: ABRILADA is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients 2 years and older.
Abrysvo (respiratory syncytial virus vaccine)
(Respiratory Syncytial Virus Vaccine)Pfizer Laboratories Div Pfizer Inc
Usage: ABRYSVO is a vaccine for the active immunization of pregnant individuals (32-36 weeks gestation), individuals 60 years and older, and those aged 18-59 at increased risk, to prevent lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in infants and adults.
Aldactazide (spironolactone and hydrochlorothiazide)
(spironolactone and hydrochlorothiazide)Pfizer Laboratories Div Pfizer Inc
Usage: ALDACTAZIDE is indicated for managing edematous conditions in congestive heart failure, cirrhosis with edema, nephrotic syndrome, and for treating essential hypertension. It is also used for diuretic-induced hypokalemia when other therapies are inadequate. Routine diuretic use during pregnancy is inappropriate unless due to pathological causes.
Beqvez (fidanacogene elaparvovec-dzkt)
(fidanacogene elaparvovec-dzkt)Pfizer Laboratories Div Pfizer Inc
Usage: BEQVEZ is a gene therapy for adults with moderate to severe hemophilia B, indicated for those on factor IX prophylaxis, experiencing life-threatening hemorrhages or serious spontaneous bleeding, and without neutralizing antibodies to AAVRh74var capsid, based on FDA-approved diagnostics.
Bosulif (bosutinib)
(Bosutinib)Pfizer Laboratories Div Pfizer Inc
Usage: BOSULIF is indicated for the treatment of adult and pediatric patients (1 year and older) with chronic phase Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML), either newly diagnosed or resistant/intolerant to prior therapy, as well as adult patients with accelerated or blast phase Ph+ CML.
Caduet (amlodipine besylate and atorvastatin calcium)
(amlodipine besylate and atorvastatin calcium)Pfizer Laboratories Div Pfizer Inc
Usage: CADUET, which contains amlodipine and atorvastatin, is indicated for patients needing both treatments. Amlodipine addresses hypertension and angina, while atorvastatin reduces cardiovascular event risks and lowers LDL cholesterol in various populations, including those with hyperlipidemia and diabetes.
Celebrex (celecoxib)
(Celecoxib)PFIZER LABORATORIES DIV PFIZER INC
Usage: CELEBREX is indicated for managing signs and symptoms of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis (in patients aged 2 years and older), ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea.
Cibinqo (abrocitinib)
(abrocitinib)Pfizer Laboratories Div Pfizer Inc
Usage: CIBINQO is indicated for treating adults and pediatric patients aged 12 and older with refractory, moderate-to-severe atopic dermatitis not adequately controlled by other systemic treatments, including biologics, or when those therapies are inadvisable. It is not recommended for use with other JAK inhibitors or immunosuppressants.
Cutaquig (immunoglobulin g)
(immunoglobulin G)Pfizer Laboratories Div Pfizer Inc
Usage: CUTAQUIG is indicated for replacement therapy in adults and pediatric patients aged 2 and older with primary humoral immunodeficiency (PI), including conditions like common variable immunodeficiency, X-linked agammaglobulinemia, and severe combined immunodeficiencies.
Daurismo (glasdegib)
(glasdegib)Pfizer Laboratories Div Pfizer Inc
Usage: DAURISMO, in combination with low-dose cytarabine, is indicated for treating newly-diagnosed acute myeloid leukemia (AML) in adults aged 75 or older or those with comorbidities that limit the use of intensive induction chemotherapy.